ASM Technologies Limited announces an acquisition
TL;DR
Does the Q2 FY27 Monitoring Agency Report disclose any material deviation between the actual utilization of preferential issue proceeds and the objects of the issue as stated in the original offer document, and what is the specific quantum of unutilized funds currently parked in liquid instruments?
No material deviation was reported. The Monitoring Agency Report summary states that the preferential issue proceeds were utilised as disclosed and that no deviations were reported against the stated objects of the issue.[1]
Unutilized funds in liquid instruments: the specific quantum could not be confirmed from the cited report summary. It should not be inferred from the approximately ₹526 Cr issue size or the stated object-wise allocations.[1]
Based on the utilization schedule in the report, what percentage of the total preferential issue proceeds has been deployed toward the stated objects (e.g., working capital, capex) as of the end of Q2 FY27, and does the current pace of deployment align with the original timeline disclosed in the issue prospectus?
The percentage deployed toward the preferential-issue objects as of Q2 FY27 cannot be confirmed from the reported figures. The monitoring-agency summary says proceeds were utilised without reported deviations, but it does not provide the object-wise deployed amounts needed to calculate:
`deployed proceeds ÷ total preferential-issue proceeds × 100` [1]
The ₹526.0 Cr issue was allocated as follows; these are planned allocations, not actual deployment:
The reported H1 FY27 consolidated capex of ₹183.35 million, or ₹18.34 Cr, should not automatically be treated as preferential-issue utilization: the filing summary does not establish that this capex was funded from the issue proceeds [3].
Timeline assessment: alignment also cannot be established. The issue was described as completed in October 2026 [4], whereas Q2 FY27 ended on 30 September 2026. Therefore, any spending recorded at the Q2-end date would precede the stated completion of the issue and cannot be attributed to the preferential proceeds without a dated, object-wise utilization schedule. The prospectus extract identifies a “tentative timeline for utilisation,” but the actual timeline milestones are not reported in the cited material [5].
Conclusion: the available evidence supports the planned allocation mix and “no deviation” statement, but not a defensible Q2-end deployment percentage or a pace-versus-prospectus-timeline test.
How does the current deployment status of the preferential issue proceeds, as detailed in the Q2 FY27 report, compare to the company's historical capital expenditure run-rate, and does the report highlight any significant changes in the planned allocation of funds toward working capital versus long-term asset creation?
Verdict: The ₹170.13 Cr preferential issue covered by the Q2 FY27 monitoring report was fully deployed by 30 September 2026, and its size was substantially larger than the company’s reported routine capex. However, the proceeds were used mainly for acquisitions, growth investments and general corporate purposes—not clearly for fixed-asset creation. The report did not identify a material shift toward working capital or away from long-term assets; it reported no major deviation from the approved objects.
Preferential issue deployment
The Q2 deployment included ₹7.45 Cr invested in Myelin Foundry’s Series Seed CCPS and ₹31.28 Cr used to acquire equity shares of Asmaitha Wireless Technologies. [7] The ₹14.85 Cr classified as general corporate purposes comprised subsidiary investment, cash-credit facility adjustment, bank charges and an Asmaitha acquisition. [8]
Compared with capex
The consolidated KPI history shows FY24 capex of ₹0.00 Cr. [9] A Q2 FY27 results summary reported consolidated H1 FY27 capex of ₹18.3 Cr, although the same summary shows Q1 capex of ₹10.5 Cr and Q2 capex of ₹18.3 Cr, making the H1 line internally non-additive. [3]
Using the reported H1 figure as a directional reference, the fully deployed ₹170.13 Cr issue proceeds were approximately 9.3x H1 FY27 capex, derived from ₹170.13 Cr divided by ₹18.3 Cr. [6] [3] This is not a like-for-like capex comparison: around 76.4% of the proceeds went toward growth opportunities and strategic acquisitions, while 23.6% went to GCP, rather than being spent on plant and equipment. [6]
Working capital versus long-term asset creation
The monitoring report’s allocation table does not provide a separate working-capital or fixed-asset-capex bucket; therefore, a precise working-capital-versus-long-term-asset split could not be confirmed from this report. [6] Its explicit conclusion was that utilization was consistent with the offer document, that the means of finance had not changed, and that there was no major deviation from earlier monitoring reports. [10]
There was a minor administrative revision of GCP from ₹40.00 Cr to ₹40.13 Cr after the full ₹170.13 Cr was received, but this was not a substantive reallocation. [6]
A separate, later approximately ₹526 Cr preferential issue announced in October 2026 should not be conflated with the ₹170.13 Cr issue monitored here. Its stated plan explicitly included ₹190.24 Cr of capex for organic growth and expansion and ₹50.06 Cr for working capital, alongside acquisitions, debt repayment and GCP. [4] [2] That is a new planned allocation, not a change in the deployment status of the earlier issue.
Sources
- [1]ASM Technologies Other Announcement | ASMTEC | 13 Nov 2026 — Alfafinder, 2026-11-13T00:00:00
- [2]ASM Technologies issues corrigendum to EGM notice for ₹526 crore preferential issue — Scanx, 2026-09-25T00:00:00
- [3]Summary of quarterly results filing for ASM Technologies Ltd published on 07 Nov, 2026 | Perivis — Perivis, 2026-11-07T00:00:00
- [4]Date: 9 November 2026 To, BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai - — D162Horukp7Uyq, 2026-11-09T00:00:00
- [5]CORRIGENDUM TO THE 01/2026-27 EXTRA-ORDINARY GENERAL MEETING Dear Members, This Corrigendum is being issued in relation to Item No. 1 — Asmltd, 2026-09-25T00:00:00
- [6]Final Monitoring Agency Report on Preferential Issue Proceeds Utilization for Q2 FY27 — 2026-11-13T23:10:08.827000, p.7
- [7]Final Monitoring Agency Report on Preferential Issue Proceeds Utilization for Q2 FY27 — 2026-11-13T23:10:08.827000, p.8
- [8]Final Monitoring Agency Report on Preferential Issue Proceeds Utilization for Q2 FY27 — 2026-11-13T23:10:08.827000, p.9
- [9]TTM Capex
- [10]Final Monitoring Agency Report on Preferential Issue Proceeds Utilization for Q2 FY27 — 2026-11-13T23:10:08.827000, p.5
Keep digging